VancomycinGlycopeptide antibiotic
Vancomycin is a glycopeptide antibiotic used against selected Gram-positive bacteria. Intravenous and oral treatment have very different purposes because the drug’s absorption changes where it can act.
What is Vancomycin?
Vancomycin is a glycopeptide antibiotic used against susceptible Gram-positive bacteria. Intravenous treatment of systemic infections and oral treatment directed at the intestine are distinct uses. 1 2
How it works
It interferes with bacterial cell-wall synthesis. Oral vancomycin is usually poorly absorbed, which helps keep its action in the bowel; intravenous administration provides systemic exposure. 2
Effects studied
What does the evidence show?
Infection-specific clinical evidence and label lead
A bacterial wall is the target
Vancomycin interferes with bacterial cell-wall construction by binding building blocks used to make it. Its useful activity is mainly against Gram-positive bacteria. It is not a broad remedy for any infection, and a susceptibility result must be interpreted alongside the site and severity of disease.
The route changes the job
Intravenous treatment delivers vancomycin into the bloodstream for systemic exposure. Oral vancomycin is generally poorly absorbed and can act within the bowel, including in selected Clostridioides difficile infections. That poor absorption is useful for a gut target but makes oral treatment inappropriate as a substitute for intravenous exposure elsewhere.
What a comparison can tell us
The retained trial compares antibiotics in a defined infection setting. That evidence is more informative than ranking drugs by how “strong” they sound. The organism, resistance pattern, control of the infection source and tissue penetration can all affect treatment choice. 1
Monitoring helps manage the trade-off
Systemic treatment can cause kidney injury and infusion reactions. Absorption from the gut is not always negligible, especially in some severely ill patients. Antibiotic exposure also affects resistance and the microbiome. Use therefore centres on treating an identified infection, rather than preventive or wellness purposes. 2
Safety & status
Kidney toxicity, infusion reactions and antimicrobial resistance are important concerns. Oral absorption is not always negligible, particularly when intestinal inflammation is severe. 2
Country and product status
Product indications and availability vary by country; current EU and Swiss status has not been independently checked for this draft.
Frequently asked questions
Can oral vancomycin replace intravenous treatment?
Not generally. Oral delivery usually produces limited systemic exposure and serves a different clinical purpose. 2
Is it useful for viruses?
No. Its described target is the bacterial cell wall, not a viral process.
Sources
This entry was rewritten from our research archive. References below are reading leads unless a completed check is explicitly noted; a full independent evidence and regulatory review is still pending.
- Retained paper reference Archive research lead · Retained archive reference; not independently checked for this draft
- Retained source reference Archive research lead · Retained archive reference; not independently checked for this draft
Research provenance
This name was discovered in the Superpower peptide index, archived 26 October 2026. Its ratings and reviewer attribution have not been adopted as our own. The archive informed this original editorial draft; independent source review is still pending.